CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $64.88 ($25,952)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $61.37 ($24,548)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Grant or award Director acquired 4,336 shares (grant or award)
- 4 Open-market sale SVP, GENERICS sold 881 shares at $60.07 ($52,922)
- 4 Open-market sale HEAD OF RARE DISEASE sold 4,000 shares at $60.45 ($241,800)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $62.20 ($24,880)
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 700 shares at $76.83 ($53,781)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $68.96 ($27,584)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,455 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & CFO gave up 6,210 shares (to pay taxes)
- 4 Planned sale SVP, CHIEF HR OFFICER sold 1,866 shares at $65.00 ($121,290)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $63.33 ($25,332)
- 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 2,874 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,060 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, GENERICS gave up 3,314 shares (to pay taxes)
Page 6 of 42 · 834 filings